[Value of experimental and clinical methods on the effectiveness and side effect profile of anti-arrhythmia agents]
- PMID: 1283932
[Value of experimental and clinical methods on the effectiveness and side effect profile of anti-arrhythmia agents]
Abstract
The suppression by antiarrhythmic drugs of ventricular premature beats, pairs and salvos is frequently not associated with a suppression of ventricular tachycardia or fibrillation in the same patient. The evaluation of antiarrhythmic drugs must therefore distinguish between antiectopic, anti-reentry and anti-fibrillatory efficacy. Clinical methods such as Holter monitoring and programmed electrical stimulation which only allow the validation of anti-ectopic or anti-reentry efficacy present a major problem in the evaluation of antiarrhythmic drugs. Anti-fibrillatory drug efficacy cannot be evaluated by clinical methods.
Similar articles
-
[Ventricular tachyarrhythmia. Drug therapy and evaluation of success].Z Kardiol. 1993;82 Suppl 5:155-61. Z Kardiol. 1993. PMID: 8154157 Review. German.
-
[A new method for the evaluation of the success of anti-arrhythmic drug therapy and a paradoxical drug-induced arrhythmogenic effect in individual patients].Z Kardiol. 1984 Aug;73(8):492-7. Z Kardiol. 1984. PMID: 6208699 German.
-
Is programmed stimulation of value in predicting the long-term success of antiarrhythmic therapy for ventricular tachycardias?N Engl J Med. 1986 Aug 7;315(6):356-62. doi: 10.1056/NEJM198608073150604. N Engl J Med. 1986. PMID: 2426592
-
[Anti-arrhythmia and pro-arrhythmia effects of oral cibenzoline therapy in sustained ventricular tachycardia].Z Kardiol. 1992 Jul;81(7):378-84. Z Kardiol. 1992. PMID: 1509795 German.
-
[Clinical evaluation of new anti-arrhythmia drugs after the CAST (Cardiac Arrhythmia Suppression Trial) study].Z Kardiol. 1992;81 Suppl 4:145-9. Z Kardiol. 1992. PMID: 1290291 Review. German.